- Single-use Vials
- Multi-use Vials
Lyophilized Injectables Market size was USD 3,482.7 million in 2023 and is expected to reach USD 6,786.8 million in 2030, growing at a CAGR of 10% from 2024-2030. Lyophilized injectables are freeze-dried formulations of drugs that offer improved stability and shelf life compared to liquid formulations. The market is witnessing growth due to factors such as increasing prevalence of chronic diseases, rising demand for biologic drugs, and advancements in lyophilization technologies.
According to the World Health Organization, the global prevalence of chronic diseases is expected to rise significantly by 2030, and each year, 17 million people die from a chronic disease before age 70; 86% of these premature deaths occur in low- and middle-income countries. driving the demand for stable and effective drug formulations. Additionally, the growing focus on personalized medicine and targeted therapies is boosting the adoption of lyophilized injectables. However, the market faced challenges during the COVID-19 pandemic, with disruptions in supply chains and manufacturing processes. The high cost of lyophilization equipment and complex manufacturing processes could also impede market growth in some regions.
Lyophilized Injectables Market Key Developments:
- In March 2024, Schott AG introduced EVERIC freeze pharmaceutical glass vials, specifically designed for deep-cold applications. These vials enhance the stability and integrity of lyophilized drugs during storage and transport, addressing critical needs in the biopharmaceutical industry.
- In April 2024, CIRON Drugs & Pharmaceuticals Pvt. Ltd opened a new state-of-the-art lyophilization facility in Mumbai, India. This facility aims to increase production capacity for lyophilized injectables, catering to the growing demand for stable and long-shelf-life injectable drugs in both domestic and international markets.
Lyophilized Injectables Market Summary
Study Period
2024-2030Base Year
2023CAGR
10.0%Largest Market
North AmericaFastest Growing Market
Asia PacificLyophilized Injectables Market Dynamics
The recent surge in demand for lyophilized injectable drugs can be directly attributed to their increasing utilization in the pharmaceutical industry. Biologics require specific formulation techniques like lyophilization to enhance stability and increase shelf life, creating a significant market driver. This surge is contributing to its rise and driving forward its market. Continuous advances in lyophilization technologies play a pivotal role in market expansion. Innovations such as novel excipient development, optimized lyophilization cycles, and improvements to freeze-drying equipment improve the manufacturing of injectable drugs with this process, thus serving as catalysts for market expansion. The market is also seeing increased interest from contract manufacturing organizations (CMOs) offering lyophilization services. However, challenges remain in terms of scaling up production, maintaining product quality during the lyophilization process, and the need for specialized packaging materials.
North-America Got Significant Share
Lyophilized Injectables Market Regional Analysis
Based on regions the lyophilized injectables market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. North America is expected to dominate the lyophilized injectables market, accounting for the largest share of the global market. This is primarily due to the presence of major pharmaceutical companies, advanced healthcare infrastructure, and high healthcare spending in countries like the United States and Canada. Europe holds a significant market share, driven by a strong focus on research and development in the pharmaceutical sector. The Asia-Pacific region is expected to show the highest growth rate during the forecast period, driven by increasing investments in healthcare infrastructure, growing pharmaceutical manufacturing capabilities, and the rising prevalence of chronic diseases.
Latin America
Europe
Asia Pacific
Middle East
North America
Lyophilized Injectables Market Segmentation
By Type
By Application
- Oncology
- Autoimmune Diseases
- Infectious Diseases
- Others
By End User
- Hospitals
- Clinics
- Others
Geography
- North America
- Europe
- The Asia Pacific
- Latin America
- MEA
Frequently Asked Questions
The global lyophilized injectables market size was USD 3,482.7 million in 2023 and is expected to reach USD 6,786.8 million in 2030, growing at a CAGR of 10% during the forecast period.
North America accounts for the highest rate of growth in the lyophilized injectables market.
The leading players in the lyophilized injectables market include Baxter International Inc., Vetter Pharma International GmbH, Jubilant HollisterStier LLC, Schott AG, and Pfizer Inc.
Key drivers include the increasing prevalence of chronic diseases, rising demand for biologic drugs, advancements in lyophilization technologies, and growing focus on personalized medicine.
Restraints include the high cost of lyophilization equipment, complex manufacturing processes, and challenges in scaling up production while maintaining product quality.
Key Features of the Report
- The lyophilized injectables market report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030).
- The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies.
- The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market.
- The report tracks recent innovations, key developments, and start-up details that are actively working in the market.
- The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenarios.
| 1.Executive Summary |
| 2.Global Lyophilized Injectables Market Introduction |
| 2.1.Global Lyophilized Injectables Market - Taxonomy |
| 2.2.Global Lyophilized Injectables Market - Definitions |
| 2.2.1.Type |
| 2.2.2.Application |
| 2.2.3.End User |
| 2.2.4.Region |
| 3.Global Lyophilized Injectables Market Dynamics |
| 3.1. Drivers |
| 3.2. Restraints |
| 3.3. Opportunities/Unmet Needs of the Market |
| 3.4. Trends |
| 3.5. Product Landscape |
| 3.6. New Product Launches |
| 3.7. Impact of COVID 19 on Market |
| 4.Global Lyophilized Injectables Market Analysis, 2019 - 2023 and Forecast 2024 - 2030 |
| 4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
| 4.3. Market Opportunity Analysis |
| 5.Global Lyophilized Injectables Market By Type, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 5.1. Single-use Vials |
| 5.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.1.3. Market Opportunity Analysis |
| 5.2. Multi-use Vials |
| 5.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 5.2.3. Market Opportunity Analysis |
| 6.Global Lyophilized Injectables Market By Application, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 6.1. Oncology |
| 6.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.1.3. Market Opportunity Analysis |
| 6.2. Autoimmune Diseases |
| 6.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.2.3. Market Opportunity Analysis |
| 6.3. Infectious Diseases |
| 6.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.3.3. Market Opportunity Analysis |
| 6.4. Others |
| 6.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 6.4.3. Market Opportunity Analysis |
| 7.Global Lyophilized Injectables Market By End User, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 7.1. Hospitals |
| 7.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.1.3. Market Opportunity Analysis |
| 7.2. Clinics |
| 7.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.2.3. Market Opportunity Analysis |
| 7.3. Others |
| 7.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 7.3.3. Market Opportunity Analysis |
| 8.Global Lyophilized Injectables Market By Region, 2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 8.1. North America |
| 8.1.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.1.3. Market Opportunity Analysis |
| 8.2. Europe |
| 8.2.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.2.3. Market Opportunity Analysis |
| 8.3. Asia Pacific (APAC) |
| 8.3.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.3.3. Market Opportunity Analysis |
| 8.4. Middle East and Africa (MEA) |
| 8.4.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.4.3. Market Opportunity Analysis |
| 8.5. Latin America |
| 8.5.1. Market Analysis, 2019 - 2023 and Forecast, 2024 - 2030, (Sales Value USD Million) |
| 8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
| 8.5.3. Market Opportunity Analysis |
| 9.North America Lyophilized Injectables Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 9.1. Type Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.1.1.Single-use Vials |
| 9.1.2.Multi-use Vials |
| 9.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.2.1.Oncology |
| 9.2.2.Autoimmune Diseases |
| 9.2.3.Infectious Diseases |
| 9.2.4.Others |
| 9.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.3.1.Hospitals |
| 9.3.2.Clinics |
| 9.3.3.Others |
| 9.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 9.4.1.United States of America (USA) |
| 9.4.2.Canada |
| 10.Europe Lyophilized Injectables Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 10.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.1.1.Single-use Vials |
| 10.1.2.Multi-use Vials |
| 10.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.2.1.Oncology |
| 10.2.2.Autoimmune Diseases |
| 10.2.3.Infectious Diseases |
| 10.2.4.Others |
| 10.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.3.1.Hospitals |
| 10.3.2.Clinics |
| 10.3.3.Others |
| 10.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 10.4.1.Germany |
| 10.4.2.France |
| 10.4.3.Italy |
| 10.4.4.United Kingdom (UK) |
| 10.4.5.Spain |
| 11.Asia Pacific (APAC) Lyophilized Injectables Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 11.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.1.1.Single-use Vials |
| 11.1.2.Multi-use Vials |
| 11.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.2.1.Oncology |
| 11.2.2.Autoimmune Diseases |
| 11.2.3.Infectious Diseases |
| 11.2.4.Others |
| 11.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.3.1.Hospitals |
| 11.3.2.Clinics |
| 11.3.3.Others |
| 11.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 11.4.1.China |
| 11.4.2.India |
| 11.4.3.Australia and New Zealand (ANZ) |
| 11.4.4.Japan |
| 11.4.5.Rest of APAC |
| 12.Middle East and Africa (MEA) Lyophilized Injectables Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 12.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.1.1.Single-use Vials |
| 12.1.2.Multi-use Vials |
| 12.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.2.1.Oncology |
| 12.2.2.Autoimmune Diseases |
| 12.2.3.Infectious Diseases |
| 12.2.4.Others |
| 12.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.3.1.Hospitals |
| 12.3.2.Clinics |
| 12.3.3.Others |
| 12.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 12.4.1.GCC Countries |
| 12.4.2.South Africa |
| 12.4.3.Rest of MEA |
| 13.Latin America Lyophilized Injectables Market ,2019 - 2023 and Forecast 2024 - 2030 (Sales Value USD Million) |
| 13.1. Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.1.1.Single-use Vials |
| 13.1.2.Multi-use Vials |
| 13.2. Application Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.2.1.Oncology |
| 13.2.2.Autoimmune Diseases |
| 13.2.3.Infectious Diseases |
| 13.2.4.Others |
| 13.3. End User Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.3.1.Hospitals |
| 13.3.2.Clinics |
| 13.3.3.Others |
| 13.4. Country Analysis 2019 - 2023 and Forecast 2024 - 2030 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
| 13.4.1.Brazil |
| 13.4.2.Mexico |
| 13.4.3.Rest of LA |
| 14. Competition Landscape |
| 14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
| 14.2.1.Baxter International Inc. |
| 14.2.2.Vetter Pharma International GmbH |
| 14.2.3.Jubilant HollisterStier LLC |
| 14.2.4.Schott AG |
| 14.2.5.Nipro Corporation |
| 14.2.6.Gerresheimer AG |
| 14.2.7.Evonik Industries AG |
| 14.2.8.Pfizer Inc. |
| 14.2.9.Mylan N.V. (Now part of Viatris Inc.) |
| 14.2.10.Teva Pharmaceutical Industries Ltd. |
| 15. Research Methodology |
| 16. Appendix and Abbreviations |
- Baxter International Inc.
- Vetter Pharma International GmbH
- Jubilant HollisterStier LLC
- Schott AG
- Nipro Corporation
- Gerresheimer AG
- Evonik Industries AG
- Pfizer Inc.
- Mylan N.V. (Now part of Viatris Inc.)
- Teva Pharmaceutical Industries Ltd.